Web Analytics

3 Latest Announced Rounds

  • $5,500,000
    Unknown

    6 Investors

    Financial Services
    May 1st, 2025
  • $3,750,000
    Pre Series A

    3 Investors

    E-learning Providers
    May 1st, 2025
  • $7,300,000
    Seed

    3 Investors

    Financial Services
    May 1st, 2025
$1,436.14M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

En Carta Diagnostics

start up
France - Paris
  • 23/05/2024
  • Pre-Seed
  • $1,623,697

Diagnostics for Better care, Everywhere.

En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.


Related People

Guillaume HorréardCo Founder

Guillaume Horréard France - Paris, Île-de-France

As the Co-founder and CEO of En Carta Diagnostics, I am dedicated to simplifying the world of diagnostics, making them as accessible as antigenic tests.
Our vision is to revolutionize healthcare by bringing diagnostics to every corner of the globe for better patient care.

Feel free to connect with me to discuss opportunities, collaboration, or to explore how we can advance healthcare and product development together.